Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation by unknown
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During development, lymphoid stem cells migrate into the thymic rudiment where
they differentiate into functionallymature T lymphocytes (1). Amonghuman thymo-
cytes, CD7 +CD2 -CD3-CD4-CD8- (referred hereafter as CD7') cells represent the
earliest identifiable step (2-4) . In vitro, these precursors were able to acquire mature
T cell antigens (3, 4), but cellular interactions and cytokines necessary for this pro-
cess are poorly understood . We have previously reported that enriched populations
of B lymphocytes from blood produce factors (3, 5) that promote in vitro develop-
ment of blood- and bone marrow-derived CD7+CD2- precursors. Comparing the
biochemical characteristics of this B cell-derived activity (3) to known B cell-de-
rived molecules, we found its striking homology to soluble CD23 (sCD23 ; sFcERII)
(6, 7) . Using recombinant sCD23 (rsCD23) (7), we then assayed the effect of this
molecule alone or with rIL-1 and/or rIL-2 on purified CD7+ thymic precursors . Our
results provide direct evidence that sCD23 and rIL-1 synergistically induce CD7 +
prothymocytes maturation into CD2'CD3'TCRa//3+CD4+ and/or CD8+ cells that
respond to CD2 triggering and rIL-2 .
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mAbandMarkerAnalysis.
￿
Used in this study were OKT6(CD1), OKT11(CD2),OKT3(CD3),
OKT4(CD4), OKT8(CD8), and OKMl(CD11b) (Ortho Pharmaceutical, Raritan, NJ) ;
IOM2(CD14), IOB4(CD19), IOB6(CD23, IgG.K), and ICT14 (CD25) (Immunotech, Mar-
seille, France); WT31 (recognizing CD3/TCRa/,8 complex ; Becton Dickinson & Co .,
Grenoble, France) ; RFT2 (CD7) (2) ; 6C2 (antiTCR ,y) (8) ; and 6TCS-1 (antiTCR-S; T Cell
Sciences, Cambridge, MA) . Fluorescein-conjugated anti-mouse F(ab')2 fragments (Becton
Dickinson & Co.) were then applied . Cell markers are evaluated using a FACStar (Becton
Dickinson & Co .) or UV microscope (E . Leitz, Inc., Rueil, France).
Cells.
￿
Thmocytes were obtained by teasing thymic fragments . Prothymocytes were iso-
Address correspondence toM . Djavad Mossalayi, Laboratoire d'Immunologie Cellulaire, H6pital Piti6-
Salpetribre, 75013 Paris, France .
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lated by two-step adherence on plastic surfaces followed by two cycles ofcytotoxic treatment
with OKT11A, OKT3, OKT4, and OKT8, and subsequentincubation with newborn rabbit
complement (3). The cells were then applied into flasks coated with RFT2 mAb (3, 5). Panned
(CD7') cells were then collected and centrifuged on Ficoll gradient to eliminate dead cells.
The recovered cell numbers correspond to -0.3% of unfractionated thymocytes.
Cell Cultures.
￿
Thymic isolated CD7' cells were incubated 48 h in MacCoy's 5A medium
containing 20% human AB serum and one or a combination of. rsCD23 (25 ng/ml) (7),
rIL-1 (50 U/ml rIL-1(3), rIL-2 (100 U/ml) (rIL-1/3 and rIL-2 were a kind gift from Glaxo,
Geneva, Switzerland), 10136 (CD23, IgG1.K), 10134 (IgGLK, 25,ug/ml), and ICT14 (10 hg/ml)
(Immunotech). The cellswere then washed and tested for their surface markers. In this assay,
>88% (range, 88-98%) ofcultured cells were recovered and viability exceeded 94%. We failed
to detect cell proliferation during this period, regardless of culture conditions used (assayed
by [3H]thymidine uptake, data not shown). For the proliferation assay, CD7' cells were first
incubated with various factors for 24 h (as above). They were then washed and cultured with
anti-C]321+111 mAb (1/400 ascite; a gift of A. Bernard, Institut Gustave Roussy, Villejuif,
France) (9) and 100 U/ml rIL-2. [3H]Thymidine was incorporated on day 5, and radioac-
tivity uptake was measured on day 6. These cells were also cultured in limiting dilutions
(3). Briefly, CD7' cells were incubated 48 h with various factors, washed, and cultured
(0.1-100 cell/well) in 96-well microplates in the presence of CD21+11j, rIL-2, and 103 autolo-
gous irradiated (5,000 rad) CD2- cells. Positive (>100 cells) vs. negative wells were scored
from day 10, as described (3).
Results and Discussion
The surface markers of CD7' cells were analyzed before and after incubation
with either rsCD23, rIL-1, rIL-2, or various combinations of these molecules. Freshly
isolated cells were mostly CD7+CD2 -CD3 -CD4- CD8- (Table I), and did not ex-
press TCRa//3 or TCR,yb. Upon incubation in culture medium alone, the pheno-
type of these precursors remained unchanged (p < 0.001), indicating that there was
no surface antigen modulation. The data in Table I show that maturation of CD7'
precursors requires both HL-1 and rsCD23, in as much as the expressionof the matu-
ration antigens (CD2, CD3, TCRa/#, CD25, CD4, and/or CD8), was observed
only in the cultures containing these two recombinant molecules (p < 0.005). This
effect was completely suppressed by anti-CD23 mAb, but not by the addition of an
isotype-matched unrelated mAb (anti-CD19, IgGLK). The elimination of CD14+,
MHC-II', and/or LFA-3' cells from CD7' cell preparations did not significantly
affect rsCD23 + rIL-1-derived responses (data not shown).
We next examined whether the acquisition of T cell differentiation antigens was
accompanied by a functional maturation. To this end, CD7+ cells, preincubated as
in Table I, were tested for their capacity to proliferate in response to a mitogenic
pair of anti-CD2 (9) and rIL-2. As seen in Fig. 1, preincubation with either rIL-1,
HL-2, or rsCD23 did not induce CD2 responsiveness. By contrast, cells preincubated
with both rsCD23 and rIL-1 showed a clear proliferative response. The addition
of rIL-2 to rsCD23 + rIL-1 further increased the growth potential (P < 0.01). These
data further confirm the absence of CD2 expression by freshly isolated CD7'
thymocytes.
To provide further evidence that prothymocyte maturation required sCD23, we
treated CD7' precursors for 48 h with increasing amounts of rsCD23 and constant
rIL-1 and HL-2 concentrations, and then we tested the proliferative responses to
anti-CD2 and rIL-2, as well as CD2 and CD3 expression. Fig. 2 shows that the rsCD23
effect is dose dependent, with an optimum of 25-75 ng/ml.MOSSALAYI ET AL .
￿
BRIEF DEFINITIVE REPORT
w
￿
b
° ~zNzzzM"'zl
a
E-1
961
r
N NzMzzz"
,
3
N M N - N M O, O, N
M M
._
y w
°
U
HI I
,
w o
O d- )r, O O -o- O, ^ M M
U a
0
Z, ^
0
A
y U
.., .-+ - .-+ N ^+ O '+ N 'b
..p U U
h
M O N ~ M N " N
° a
p N
o,
w
K
~
U
N M N O O T M ~) t\ M O', O, O, O, OW O, O', O, N
017
C
c
y
a
N N O - N ~ n W M
u
E
U =o
E
U U
~ M ^+ O N N N M M q. C
b
a
co d'
U
N ^ N ~ N M M .~+ M N N w .a _ .
U
M d' M N M d' U~ ~:; u') 7
A w .-
s0 . O
d
N 'It . d+ M M ~ 1~ >`
N >
O
O
a .5 V
M =
.~ .
cli
A
c, U
a'~
E M y
s~
EEE
u
i . e0 ~°
70 c-,
~ N a r-a a ra
4 N L
r
a 4 r ~
Cd V
O O N ,~ O
h
y 'b ~,_M t M M M M N N N N N VU w
O ., N
h ?~ oaaA .SoAAQ
+
y w o z L L r! t n f2 4 fq .,
0
~
w ~..
U962
￿
MOSSALAYI ET AL.
￿
BRIEF DEFINITIVE REPORT
Finally, the effect of CD7+ cell preincubation with rsCD23, rIL-1, and rIL-2 on
the induction of clonogenic cells in limiting dilution and the effect of anti-CD23
mAb addition were tested. As shown in Fig. 3, rsCD23 + rIL-1-supplemented cul-
tures displayed acloning frequencyof 1/2.5, while otherculture conditions remained
inefficient in this respect. Addition ofanti-CD23 to primary cultures drastically de-
creased the number of clonogenic cells.
Together, these results indicate that sCD23, synergistically with IL-1, is able to
induce oneofthe first steps in Tcell differentiation, which is the acquisition ofCD2,
CD25, CD3, CD4, CD8, and TCRa//3 expression by immature CD7+ precursors,
although TCR repertoire of cell progeny was not defined.
CD23 was initiallyconsidered as a B cell differentiation marker (10). Subsequently,
this molecule was shown to be identical to the low affinity receptor for IgE (Fcc-RII),
which may also be expressed on monocytes/macrophages, eosinophiles, platelets,
some T cells, and epidermal Langerhans cells (6). CD23 is a 45-kD membrane gly-
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FIGURE 1. Proliferative re-
sponse after in vitro condi-
tioning of thymic CD7+ pre-
cursors. CD7+ cells were first
incubated with various factors
for 24 h (as in Table I). They
were then washed andcultured
(5 x 104/well) with anti-CD2I+m
mAb (1/400 ascites) and 100
CDxa
￿
U/ml rIL-2. [3H]Thymidine (1
Iix
￿
IACi) was added on day 5, and
radioactivity uptake was mea-
sured on day 6. Results are
mean ± SD from four experi-
ments, each done in triplicates.
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FIGURE 2.
￿
Responses of CD7+ precursors to increasing concentrations of rsCD23. CD7+
thymocytes were cultured with constant rIL-1 concentration (50U/ml)andvarious rsCD23 doses
(as in Table I), washed, and labeled with OKTII (CD2) and OKT3 (CD3). The results show
thepercentage of precursors acquiringboth CD2 and CD3 expression (") (mean t SD from
two experiments). The effects on the proliferative responses of the treated cells (as in Fig. 1) are
also shown (bars) (mean from two experiements in triplicates; SD <25%).coprotein that is cleaved into soluble fragments, and its expression is induced by
IL-4 and suppressed by IFN-a (6). Soluble CD23 was reported to control the syn-
thesis ofhuman IgE (9), to regulate the proliferation ofB (11) and Tcells (12), and
to promote early B cell differentiation (13). We previously reported the ability of
supernatants fromlectin-stimulated, enrichedB cells topromotein vitro prothymo-
cyte differentiation (3, 5). The present work indicates that sCD23, together with
IL-1, have similaractivityas they promote in vitro maturation ofCD7+ prothymo-
cytes into CD2-responsive cells. These factors seem to directly trigger prothymo-
cytes. Indeed, epithelial and other thymic accessory cell depletion after treatment
by CD14, CD58, and anti-MHC-II mAb and complement did not significantly re-
duce cell maturation.
WhetherCD23 isexpressedintrathymically remainstobeestablished. Alownumber
of CD23+ B lymphocytes have been observed in human thymus (14). As CD23 is
expressed by other cells, it remains possible that thymic accessory cells, including
epithelial cells, express CD23. In regard to IL-1, Le et al. (15) have documented
IL-1 production by human thymic epithelium after in vitro incubation with autolo-
gous thymocytes. IL-1 is known to indirectly induce IL-2 responsiveness in mature
thymocytes (19).
Although the respective roles ofIL-1 and sCD23 remain to be determined, taken
collectively, these data show that the first maturation steps during T cell develop-
ment need factor(s) distinct from IL-2.
Summary
The abilityofhuman thymus-derived CD7+CD2-CD3_ cells to acquire mature
Tcell antigens was assessed. Purified CD7+ thymocytes were incubated with rIL-
1, rIL-2, and/or recombinantsolubleCD23 (1sCD23). Short-term incubation ofthese
cells with only rsCD23 + rIL-1 induced mature T cell antigen expression on at
least halfof the cells. The induction of CD2 was functionally significant, as these
cells became able to respond to CD2 triggering and could proliferate in response
to IL-2. Possible sources of CD23 in the thymus are under investigation.
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FIGURE 3.
￿
Synergistic effect of rsCD23 and
rIL-1 on the cloning capacity of CD7'
precursors. The latter were incubated with
rsCD23 (25 ng/ml), rIL-l (50 U/ml), anti-
CD23 (25 kg/ml), and/or rIL-2 (100 U/ml)
for48 h, washed,andcultured in limiting di-
lutions in thepresence of CD21+ni and rIL-
2. Positive vs. negative wellswere scored from
day 10 after cultures.964
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